UPDATE: August 12, 2020 3PM

COVID-19 Cases by Geography to Date
per Pennsylvania Department of Health
Data updated as of 12:00pm on 8/12/2020
County Total Cases 1 Confirmed Cases Probable Cases Negative Tests 2 Deaths New cases since 8/11 New deaths since 8/11
Pennsylvania 121,130 117,739 3,391 1,271,976 7,385 +849 +33
10-County Region 15,234 14,710 524 232,956 466 +181 +7
Allegheny 9,078 8,837 241 125,169 259 +70 +5
Armstrong 230 229 1 4,352 8 +8
Beaver 1,351 1,313 38 13,594 93 +19 +1
Butler 695 637 58 14,770 16 +18 +1
Fayette 582 563 19 10,138 6 +20
Greene 118 108 10 3,119 1 +1
Indiana 335 314 21 6,239 7 +9
Lawrence 401 346 55 5,634 16 +9
Washington 871 833 38 17,332 13 +9
Westmoreland 1,573 1,530 43 32,609 47 +18

 

1 Total case counts include confirmed and probable cases.
2 Negative case data only includes negative PCR tests. Negative case data does not include negative antibody tests.
Case data from PA-NEDSS.  Death data is a combination of PA-NEDSS and EDRS

 

COVID-19 Tests to Date and Cases per 100K
per Pennsylvania Department of Health
Data updated as of 12:00pm on 8/12/2020
County Total Tested per 100K 1 Change from 8/5 Cases per 100K 2 Change from 8/5
Pennsylvania 10,891 8.4% 85.31 -11.4%
10-County Region 9,732 8.9% 98.19 -17.8%
Allegheny 10,954 8.2% 110.97 -26.2%
Armstrong 6,908 9.4% 84.43 -16.4%
Beaver 8,955 10.9% 104.86 -21.5%
Butler 8,289 11.1% 58.42 -1.8%
Fayette 8,103 12.6% 173.86 60.8%
Greene 8,715 7.5% 40.38 -21.1%
Indiana 7,666 9.0% 109.61 -4.1%
Lawrence 6,906 10.4% 93.84 -19.6%
Washington 8,771 10.2% 77.57 -11.5%
Westmoreland 9,635 7.6% 62.58 -14.9%

 

1 Tested per 100,000 residents represents the cumulative sum of tests within the specified geography

2 Cases per 100K represents the 14 day sum of new cases per 100,000 residents’

 

REGIONAL: COVID-19 Cases Associated with
Nursing Homes and Personal Care Homes to Date
per Pennsylvania Department of Health
Data updated as of 12:00pm on 8/12/2020
County Facilities with Cases Cases Among Residents Cases Among Employees
10-County Region 178 1,881 566
Allegheny 89 1,018 351
Armstrong 7 40 9
Beaver 8 483 70
Butler 15 27 17
Fayette 6 9 11
Greene 2 2 2
Indiana 11 29 10
Lawrence 8 47 38
Washington 10 36 8
Westmoreland 22 190 50

 

State Coronavirus Updates

  • 8.11.2020 Governor Wolf
    • Press conference around a manufacturing expansion that is focusing on COVID testing.
  • Wolf Administration: Medical Device Company OraSure Expansion to Increase COVID-19 Testing Capabilities, Bring New Jobs: Governor Tom Wolf announced that OraSure Technologies Inc., a developer and manufacturer of rapid diagnostic tests, collection and stabilization devices headquartered in Northampton County, will expand its manufacturing operations in the Lehigh Valley, creating 177 new, full-time jobs and retaining 233 jobs. Read more: https://dingo.telicon.com/PA/library/2020/2020081193.HTM

 

Regional Coronavirus Updates

 

Federal Coronavirus Updates

  • Department of Health and Human Services
  • Department of Labor
    • Statement By U.S. Secretary Of Labor Scalia On Presidential Memorandum Authorizing The Other Needs Assistance Program For Major Disaster Declarations Related To Coronavirus Disease 2019: S. Secretary of Labor Eugene Scalia issued the following statement regarding the signed Presidential Memorandum Authorizing the Other Needs Assistance Program for Major Disaster Declarations Related to Coronavirus Disease 2019: Read more: https://www.dol.gov/newsroom/releases/osec/osec20200808
    • ICYMI: U.S. Department Of Labor Acts To Help American Workers And Employers During The Coronavirus Pandemic: Last week, the U.S. Department of Labor took a range of actions to aid American workers and employers as our nation combats the coronavirus pandemic. Read more: hhttps://www.dol.gov/newsroom/releases/osec/osec20200809
  • National Institutes of Health
    • Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling: Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults at clinical trial sites in the United States. Many of the trial sites and study investigators are part of the COVID-19 Prevention Network (CoVPN), recently established by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). The trials are enrolling adults who are at risk of infection due to close contact at work or home to persons with SARS-CoV-2 infection. Read more: https://www.nih.gov/news-events/news-releases/clinical-trials-monoclonal-antibodies-prevent-covid-19-now-enrolling

 

National Coronavirus Updates